The demethylating agent decitabine at a low dose was proved to restore the methylation level and expression of PD-1 on CD8+ T cells and reduce the cytotoxicity of CTLs of ITP patients. Here, PDCD1 is linked to autoimmune thrombocytopenic purpura.